title: Commentary on the challenges of establishing gene medicines as a new class of therapeutics.
authors.affiliation: Valentis, Inc., Burlingame, CA 94010, USA. Ben@valentis.com
authors.forename: B F
authors.initials: BF
authors.lastname: McGraw
mesh_terms: D003142:Communication; D015316:Genetic Therapy / Q000639:trends*; D006801:Humans